Med BioGene, Inc.

Med BioGene, Inc.

Sector: Medical Laboratories Region: Canada

: | TSX Venture Exchange: MBI | OTC Markets: MBGNF

Similar to: EpiStem Holdings Plc

Med BioGene, Inc. operates as a life science company which focuses on managing the license and rights to GeneFx Lung, a proprietary gene expression-based test for early-stage non-small-cell lung cancer. GeneFx Lung is expected to provide better-informed and personalized treatment decisions to assist in the selection of patients for adjuvant chemotherapy. Med BioGene was founded on April 28, 2006 and is headquartered in Vancouver, Canada.

News & Analysis

You may also be interested in: